Related Experiment Videos
Vigabatrin in intractable childhood epilepsy: a retrospective study
J M Gibbs1, R E Appleton, L Rosenbloom
1Department of Neurology, Royal Liverpool Children's Hospital, Alder Hey, England.
Pediatric Neurology
|September 1, 1992
Summary
Vigabatrin effectively reduced complex partial seizures in children with intractable epilepsy, with over half experiencing significant improvement. While generalized tonic-clonic seizures also improved, other seizure types showed no change, and the drug was well-tolerated.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Intractable epilepsy presents significant treatment challenges.
- Identifying effective antiepileptic drugs is crucial for patient management.
Purpose of the Study:
- To evaluate the efficacy and tolerability of vigabatrin in pediatric patients with intractable epilepsy over a 6-month period.
Main Methods:
- A study involving 43 pediatric patients with intractable epilepsy.
- Assessment of seizure frequency reduction, focusing on complex partial seizures, generalized tonic-clonic seizures, absence seizures, and myoclonic seizures.
Main Results:
- Over 50% of children with complex partial seizures (with or without secondary generalization) achieved >50% seizure reduction.
- Improvements were noted in generalized tonic-clonic seizures, but not in absence or myoclonic seizures.
- Four patients achieved seizure freedom with vigabatrin monotherapy.
- Vigabatrin was generally well-tolerated with minimal side effects.
Conclusions:
- Vigabatrin demonstrates significant efficacy in reducing complex partial seizures in children with intractable epilepsy.
- The drug shows potential as a well-tolerated monotherapy option for specific seizure types.
- Further research may explore long-term effects and optimal use in diverse epilepsy syndromes.